Patient Guide: A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 140 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04294810
Status: ACTIVE_NOT_RECRUITING
Condition: Non-Small Cell Lung Cancer
Phase: PHASE3

Where You Can Participate

This study is available at 140 locations across the country.

Top locations include:
  • • Denver, Colorado
  • • New Haven, Connecticut
  • • Saint Petersburg, Florida
  • • And 137 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer - Join Clinical Trial NCTNCT04294810

How to Join This Clinical Trial - NCTNCT04294810

Learn how to participate in this PHASE3 trial studying an investigational therapy for Non-Small Cell Lung Cancer. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Non-Small Cell Lung Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Non-Small Cell Lung Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04294810 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 140 locations. Find a study site near you:

Clinical Research Site

Denver, Colorado 80220 - United States

Status: Contact for availability

Clinical Research Site

New Haven, Connecticut 06520 - United States

Status: Contact for availability

Clinical Research Site

Saint Petersburg, Florida 33705 - United States

Status: Contact for availability

Clinical Research Site

Tallahassee, Florida 32308 - United States

Status: Contact for availability

Clinical Research Site

Saint Paul, Minnesota 55102 - United States

Status: Contact for availability

Clinical Research Site

Nashville, Tennessee 37203 - United States

Status: Contact for availability

Clinical Research Site

Fairfax, Virginia 22031 - United States

Status: Contact for availability

Clinical Research Site

Salem, Virginia 24153 - United States

Status: Contact for availability

Clinical Research Site

Vancouver, Washington 98684 - United States

Status: Contact for availability

Clinical Research Site

Woolloongabba, Queensland 4102 - Australia

Status: Contact for availability

And 130 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Non-Small Cell Lung Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships